Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-776

2 FDA label images from Avenacy, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 83634-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fos0f 0001 01)

Structural Formula (Fos0f 0001 01)
Chemical structure of fosaprepitant dimeglumine, depicting the molecular arrangement of atoms in the active ingredient.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fos0f 0001 02)

Package Label – Principal Display Panel – Vial Label (Fos0f 0001 02)
Fosaprepitant for Injection 150 mg per vial label for a single-dose vial. Contains sterile lyophilized powder for intravenous use. The label indicates storage refrigeration at 2°C to 8°C and stability of the reconstituted solution for 24 hours at room temperature or below 25°C. Manufactured for Avenacy, LLC, Schaumburg, IL, made in China, with barcode and lot/expiration placeholders visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.